Yoshiki Higa

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

I. Endo, Toshio Matsumoto, K. Tanimoto, 2020, Cancers.

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2

I. Endo, Toshio Matsumoto, K. Tanimoto, 2023, Antioxidants.

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

I. Endo, H. Sakaue, Toshio Matsumoto, 2022, Clinical & translational immunology.

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

I. Endo, K. Tanimoto, M. Abe, 2021, Haematologica.

Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis

H. Kiyonari, S. Kato, T. Nakashima, 2021, Nature Communications.

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

I. Endo, M. Abe, E. Tanaka, 2023, International Journal of Hematology.

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.

Kiyoe Kurahashi, I. Endo, M. Hiasa, 2024, International journal of hematology.